Summit Creek Advisors LLC Repligen Corp Transaction History

Summit Creek Advisors LLC

  • $778 Million
  • Q1 2024

A detailed history of Summit Creek Advisors LLC transactions in Repligen Corp stock. As of the latest transaction made, Summit Creek Advisors LLC holds 21,805 shares of RGEN stock, worth $2.75 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
21,805
Previous 21,663 0.66%
Holding current value
$2.75 Million
Previous $3.9 Million 2.95%
% of portfolio
0.52%
Previous 0.52%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$170.78 - $208.42 $24,250 - $29,595
142 Added 0.66%
21,805 $4.01 Million
Q4 2023

Feb 07, 2024
SELL
$114.17 - $185.35 $209,616 - $340,302
-1,836 Reduced 7.81%
21,663 $3.9 Million
Q3 2023

Oct 30, 2023
BUY
$138.78 - $176.51 $10,408 - $13,238
75 Added 0.32%
23,499 $3.74 Million
Q2 2023

Aug 09, 2023
BUY
$138.42 - $180.31 $1,384 - $1,803
10 Added 0.04%
23,424 $3.31 Million
Q1 2023

May 05, 2023
SELL
$154.26 - $198.1 $4.53 Million - $5.82 Million
-29,363 Reduced 55.64%
23,414 $3.94 Million
Q4 2022

Feb 10, 2023
SELL
$162.42 - $220.56 $2.99 Million - $4.06 Million
-18,401 Reduced 25.85%
52,777 $8.94 Million
Q3 2022

Nov 01, 2022
SELL
$160.42 - $256.21 $396,397 - $633,094
-2,471 Reduced 3.36%
71,178 $13.3 Million
Q2 2022

Aug 11, 2022
BUY
$140.68 - $188.02 $4.77 Million - $6.38 Million
33,916 Added 85.36%
73,649 $12 Million
Q1 2022

May 09, 2022
BUY
$161.19 - $257.96 $308,034 - $492,961
1,911 Added 5.05%
39,733 $7.47 Million
Q4 2021

Feb 10, 2022
BUY
$247.59 - $304.47 $263,435 - $323,956
1,064 Added 2.89%
37,822 $10 Million
Q3 2021

Nov 08, 2021
BUY
$194.77 - $324.21 $496,468 - $826,411
2,549 Added 7.45%
36,758 $10.6 Million
Q2 2021

Aug 04, 2021
SELL
$165.87 - $220.95 $207,337 - $276,187
-1,250 Reduced 3.53%
34,209 $6.83 Million
Q1 2021

Apr 20, 2021
SELL
$180.37 - $226.26 $194,438 - $243,908
-1,078 Reduced 2.95%
35,459 $6.89 Million
Q4 2020

Jan 20, 2021
SELL
$148.08 - $206.57 $1.14 Million - $1.6 Million
-7,730 Reduced 17.46%
36,537 $7 Million
Q3 2020

Oct 14, 2020
SELL
$122.51 - $158.27 $541,494 - $699,553
-4,420 Reduced 9.08%
44,267 $6.53 Million
Q2 2020

Jul 15, 2020
SELL
$94.33 - $140.48 $2,829 - $4,214
-30 Reduced 0.06%
48,687 $6.02 Million
Q1 2020

Apr 27, 2020
SELL
$84.96 - $109.14 $2.97 Million - $3.82 Million
-35,010 Reduced 41.81%
48,717 $4.7 Million
Q4 2019

Jan 17, 2020
SELL
$73.84 - $93.08 $36,920 - $46,540
-500 Reduced 0.59%
83,727 $7.75 Million
Q3 2019

Oct 16, 2019
SELL
$76.65 - $95.51 $23,761 - $29,608
-310 Reduced 0.37%
84,227 $6.46 Million
Q2 2019

Jul 19, 2019
BUY
$54.2 - $85.95 $12,466 - $19,768
230 Added 0.27%
84,537 $7.27 Million
Q1 2019

Apr 15, 2019
SELL
$49.45 - $62.8 $65,768 - $83,524
-1,330 Reduced 1.55%
84,307 $4.98 Million
Q4 2018

Jan 15, 2019
SELL
$48.26 - $68.88 $1.34 Million - $1.91 Million
-27,780 Reduced 24.49%
85,637 $4.52 Million
Q3 2018

Oct 11, 2018
SELL
$46.8 - $58.97 $1.84 Million - $2.32 Million
-39,260 Reduced 25.71%
113,417 $6.29 Million
Q2 2018

Jul 17, 2018
SELL
$35.26 - $47.04 $498,576 - $665,145
-14,140 Reduced 8.48%
152,677 $7.18 Million
Q1 2018

Apr 16, 2018
BUY
$30.92 - $37.27 $2.74 Million - $3.31 Million
88,766 Added 113.73%
166,817 $6.04 Million
Q4 2017

Jan 16, 2018
SELL
$32.53 - $38.92 $20,331 - $24,325
-625 Reduced 0.79%
78,051 $2.83 Million
Q3 2017

Oct 17, 2017
BUY
$36.98 - $46.06 $2.91 Million - $3.62 Million
78,676
78,676 $3.02 Million

Others Institutions Holding RGEN

# of Institutions
522
Shares Held
53.2M
Call Options Held
1.05M
Put Options Held
228K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Summit Creek Advisors LLC Portfolio

Follow Summit Creek Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Creek Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Creek Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email